Chiara Corti
Chiara Corti
European Institute of Oncology ( IEO ) / The University of Milan
Verified email at
Cited by
Cited by
Mismatch repair protein loss as a prognostic and predictive biomarker in breast cancers regardless of microsatellite instability
N Fusco, G Lopez, C Corti, C Pesenti, P Colapietro, G Ercoli, G Gaudioso, ...
JNCI Cancer Spectrum 2 (4), pky056, 2018
SARS-CoV-2 vaccines for cancer patients: a call to action
C Corti, E Crimini, P Tarantino, G Pravettoni, AMM Eggermont, S Delaloge, ...
European journal of cancer 148, 316-327, 2021
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
P Tarantino, R Carmagnani Pestana, C Corti, S Modi, A Bardia, ...
CA: A Cancer Journal for Clinicians, 2021
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, EG Rocco, ...
Genes 11 (7), 719, 2020
Seroconversion rate after vaccination against COVID-19 in patients with cancer -a systematic review
C Corti, G Antonarelli, F Scotté, JP Spano, J Barrière, JM Michot, F André, ...
Annals of Oncology, 2021
Commentary: SARS-CoV-2 vaccines and cancer patients
C Corti, G Curigliano
Annals of Oncology, 2021
Immunotherapy for early triple negative breast cancer: research agenda for the next decade
P Tarantino, C Corti, P Schmid, J Cortes, EA Mittendorf, H Rugo, ...
NPJ Breast Cancer 8 (1), 23, 2022
Therapeutic vaccines for breast cancer: Has the time finally come?
C Corti, PPMB Giachetti, AMM Eggermont, S Delaloge, G Curigliano
European Journal of Cancer 160, 150-174, 2022
HER2 low, ultra-low, and novel complementary biomarkers: expanding the spectrum of HER2 positivity in breast cancer
K Venetis, E Crimini, E Sajjadi, C Corti, E Guerini-Rocco, G Viale, ...
Frontiers in Molecular Biosciences, 2022
Therapeutic cancer vaccines revamping: technology advancements and pitfalls
G Antonarelli, C Corti, P Tarantino, L Ascione, J Cortes, P Romero, ...
Annals of Oncology 32 (12), 1537-1551, 2021
Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up
M Invernizzi, C Corti, G Lopez, A Michelotti, L Despini, D Gambini, ...
BMC cancer 18 (1), 1-12, 2018
Antibody–Drug Conjugates for the Treatment of Breast Cancer
C Corti, F Giugliano, E Nicolò, L Ascione, G Curigliano
Cancers 13 (12), 2021
Determination of mismatch repair status in human cancer and its clinical significance: does one size fit all?
C Corti, E Sajjadi, N Fusco
Advances in Anatomic Pathology 26 (4), 270-279, 2019
Targeting brain metastases in breast cancer
C Corti, G Antonarelli, C Criscitiello, N Lin U, J Cortes, P Poortmans, ...
Cancer Treatment Reviews 103 (102324), 2021
PTEN expression as a complementary biomarker for mismatch repair testing in breast cancer
G Lopez, M Noale, C Corti, G Gaudioso, E Sajjadi, K Venetis, D Gambini, ...
International Journal of Molecular Sciences 21 (4), 1461, 2020
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta …
F Conforti, L Pala, E Pagan, C Corti, V Bagnardi, P Queirolo, C Catania, ...
ESMO open 6 (5), 100251, 2021
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
E Nicolò, F Giugliano, L Ascione, P Tarantino, C Corti, SM Tolaney, ...
Cancer Treatment Reviews, 102395, 2022
First line treatment of BRAF mutated advanced melanoma: Does one size fit all?
F Giugliano, E Crimini, P Tarantino, P Zagami, J Uliano, C Corti, ...
Cancer Treatment Reviews 99, 102253, 2021
Benefit of Adjuvant Chemotherapy in Patients with Lobular Breast Cancer: a Systematic Review of the Literature and Metanalysis
GC D Trapani, S Gandini, C Corti, E Crimini, F Bellerba, I Minchella, C ...
Cancer Treatment Reviews, 2021
Bystander effect of antibody-drug conjugates: fact or fiction?
F Giugliano, C Corti, P Tarantino, F Michelini, C G
Current Oncology Reports, 2022
The system can't perform the operation now. Try again later.
Articles 1–20